During the past decade, Wojewodzki Szpital Zespolony W Elblagu conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 10 clinical trials were completed, i.e. on average, 142.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wojewodzki Szpital Zespolony W Elblagu" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Bristol-Myers Squibb" with 1 trials sponsored, "Can-Fite BioPharma" with 1 trials sponsored, "Cephalon, Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wojewodzki Szpital Zespolony W Elblagu" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Wojewodzki Szpital Zespolony W Elblagu" are "Arthritis, Rheumatoid" (4 trials), "Rheumatoid Arthritis" (4 trials), "Atopic Dermatitis" (1 trials), "Fibromyalgia" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Wojewodzki Szpital Zespolony W Elblagu" in a lesser frequency.

Most popular intervention types in "Wojewodzki Szpital Zespolony W Elblagu" are "Drug" (13 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "BI 695501" (2 trials), "Placebo" (2 trials), "Amrubicin" (1 trials), "BI 695500" (1 trials) and "BI 695501 Autoinjector" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wojewodzki Szpital Zespolony W Elblagu" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Wojewodzki Szpital Zespolony W Elblagu". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Wojewodzki Szpital Zespolony W Elblagu, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Wojewodzki Szpital Zespolony W Elblagu, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Wojewodzki Szpital Zespolony W Elblagu has several departments that took part in Clinical trials: "Wojewodzki Szpital Zespolony w Elblagu Oddzial Onkologiczny" - 4 trials, "Wojewodzki Szpital Zespolony w Elblagu, Oddzial Kardiologiczny z Pododdzialem Kardiologii Inwazyjnej" - 2 trials, "Wojewodzki Szpital Zespolony; Oddzial Reumatologii" - 2 trials